DJ Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ shed 1.45% to $55.90 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.01% to 6,921.46 and the Dow Jones Industrial Average rising 0.55% to 49,266.11.
The stock's fall snapped a two-day winning streak.
Bristol Myers Squibb Co. closed 11.73% below its 52-week high of $63.33, which the company reached on March 11th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.84% to $205.75, Pfizer Inc. $(PFE)$ rose 0.04% to $25.29, and Abbott Laboratories $(ABT)$ fell 0.68% to $126.18.
Trading volume (12.0 M) remained 4.1 million below its 50-day average volume of 16.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled January 8, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 08, 2026 16:38 ET (21:38 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments